http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201412327-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8983a064d5a6c9324e4285203084e02a |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate | 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2a8fe549e2916008f7354e6d5c429a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0322dc54eb5818a6bebcd695dd0bbd54 |
publicationDate | 2014-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201412327-A |
titleOfInvention | Use of pigment epithelium-derived factor-derived multi-peptide for the treatment of osteoarthritis |
abstract | The present specification discloses a PEDF synthetic peptide having 20 to 39 amino acid residues and having a sequence having at least 80% amino acid sequence similarity to the amino acid sequence of SEQ ID NO: 1. The synthetic peptide has at least 20 contiguous amino acid residues having at least 90% amino acid sequence similarity to the 11-30 amino acid residues of SEQ ID NO: 1. The present specification discloses compositions containing such synthetic peptides and uses thereof. According to various embodiments described herein, the synthetic peptide can be used to treat osteoarthritis. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112672731-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3761958-A4 |
priorityDate | 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 359.